Improving the health, safety, and quality of life of our youngest patients.
Medical devices designed for kids lag five to ten years behind adult technologies. We are funded by the FDA’s Office of Orphan Products Development to help pediatric device innovators accelerate high-value, high-impact solutions towards commercialization and clinical use.
Special Events & Deadlines
If you are to succeed in commercializing a medical device, you need a clear path to reimbursement. Join the Rosenman Institute to get the full briefing from Ali Samiian, Global Head of Market Access, Health Economics and Pricing at Abbott Diabetes Care.